List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 164 studies with search of: "Benzoates"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: sodium phenylacetate and sodium benzoate injection 10% / 10%;   Drug: placebo solution (10% dextrose)
2 Completed
Has Results 		Drug Study in Pediatric Subjects With Migraines
Condition: Migraine Disorders
Interventions: Drug: rizatriptan benzoate (5 mg);   Drug: rizatriptan benzoate (10 mg);   Drug: Comparator: Placebo
3 Completed Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
Condition: Amino Acid Metabolism, Inborn Errors
Interventions: Drug: Sodium Benzoate;   Drug: Sodium Phenylacetate;   Drug: Sodium Phenylbutyrate;   Behavioral: Dietary Intervention
4 Completed A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis
Condition: Migraine
Interventions: Drug: rizatriptan benzoate;   Drug: Comparator: placebo
5 Recruiting A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents
Condition: Acute Migraine With or Without Aura in Children and Adolescents.
Interventions: Drug: rizatriptan benzoate;   Drug: Comparator: Placebo
6 Completed A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine
Condition: Acute Migraine
Interventions: Drug: rizatriptan benzoate;   Drug: Comparator: Placebo;   Drug: Comparator: Sumatriptan
7 Recruiting A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents
Condition: Acute Migraine With or Without Aura
Intervention: Drug: rizatriptan benzoate
8 Completed
Has Results 		Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study
Condition: Migraine Headache
Interventions: Drug: rizatriptan benzoate;   Drug: Comparator: sumatriptan;   Drug: Comparator: Placebo
9 Completed Treatment of Multiple Attacks of Acute Migraine
Condition: Migraine Headache
Interventions: Drug: rizatriptan benzoate;   Drug: Comparator: Placebo
10 Completed
Has Results 		Study to Test Rizatriptan in the Early Treatment of Acute Migraine
Condition: Migraine
Interventions: Drug: Comparator: rizatriptan benzoate;   Drug: Comparator: Placebo
11 Completed Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain
Conditions: Cancer;   Pain
Interventions: Drug: Caffeine;   Drug: Normal saline
12 Completed MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study
Condition: Migraine Headache
Interventions: Drug: rizatriptan benzoate (MK0462);   Drug: Comparator: sumatriptan;   Drug: Comparator: Placebo
13 Completed MK0462 in Treatment of Migraine With Recurrence
Condition: Migraine Headache
Interventions: Drug: rizatriptan benzoate (MK0462);   Drug: Comparator: placebo
14 Completed Study to Test an Approved Product in the Early Treatment of Migraine
Condition: Migraine
Interventions: Drug: MK0462, rizatriptan benzoate / Duration of Treatment: 1day;   Drug: Comparator: placebo / Duration of Treatment: 1 day
15 Completed Study to Test a Marketed Drug in the Treatment of Menstrual Migraine
Condition: Migraine
Interventions: Drug: MK0462, rizatriptan benzoate / Duration of Treatment -1 day;   Drug: Comparator: placebo / Duration of Treatment - 1 day
16 Completed Study to Test a Marketed Drug in the Treatment of Menstrual Migraine
Condition: Migraine
Interventions: Drug: MK0462, rizatriptan benzoate / Duration of Treatment -1day;   Drug: Comparator: placebo / Duration of Treatment - 1 day
17 Completed Study to Test an Approved Product in the Early Treatment of Migraine
Condition: Migraine
Interventions: Drug: MK0462, rizatriptan benzoate / Duration of Treatment: 1day;   Drug: Comparator: placebo / Duration of Treatment: 1 day
18 Completed
Has Results 		Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
19 Recruiting Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL
Conditions: Acute Promyelocytic Leukemia;   APL
Intervention: Drug: Tamibarotene
20 Recruiting Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension
Condition: Hypertension
Interventions: Drug: telmisartan;   Drug: telmisartan + hydrochlorothiazide

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services